Variant report
Variant | esv3376711 |
---|---|
Chromosome Location | chr1:104674629-104677627 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:104330211..104331667-chr1:104674701..104675769,4 | MCF-7 | breast: | |
2 | chr1:104490807..104491700-chr1:104674682..104675320,2 | MCF-7 | breast: | |
3 | chr1:104330809..104331725-chr1:104675161..104675727,2 | MCF-7 | breast: | |
4 | chr1:104659954..104662571-chr1:104673545..104675551,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548943821 | chr1:104674662-104674663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529948892 | chr1:104674669-104674670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111543122 | chr1:104674674-104674675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75745802 | chr1:104674695-104674696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533825343 | chr1:104674708-104674709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4528126 | chr1:104674734-104674735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552224013 | chr1:104674742-104674743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113264384 | chr1:104674750-104674751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537427051 | chr1:104674772-104674773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs63574660 | chr1:104674774-104674775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79492021 | chr1:104674776-104674777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74405698 | chr1:104674778-104674779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs386634111 | chr1:104674782-104674783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs61788850 | chr1:104674783-104674784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs63376460 | chr1:104674790-104674791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368741827 | chr1:104674793-104674794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs386634112 | chr1:104674795-104674796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61788852 | chr1:104674796-104674797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62987060 | chr1:104674797-104674798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536084903 | chr1:104674869-104674870 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116775298 | chr1:104674912-104674913 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183335119 | chr1:104674945-104674946 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570641146 | chr1:104674960-104674961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77408816 | chr1:104674975-104674976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576414295 | chr1:104675026-104675027 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142370538 | chr1:104675083-104675084 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543451868 | chr1:104675098-104675099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs562844400 | chr1:104675124-104675125 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72989543 | chr1:104675237-104675238 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs548409692 | chr1:104675257-104675258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556870752 | chr1:104675329-104675330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115536337 | chr1:104675404-104675405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79245908 | chr1:104675425-104675426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552335616 | chr1:104675460-104675461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371978307 | chr1:104675473-104675474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12728437 | chr1:104675502-104675503 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs139868304 | chr1:104675579-104675580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568742499 | chr1:104675580-104675581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552973037 | chr1:104675587-104675588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542504245 | chr1:104675591-104675592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535702388 | chr1:104675610-104675611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187892871 | chr1:104675677-104675678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112083722 | chr1:104675691-104675692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572341494 | chr1:104675699-104675700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539623818 | chr1:104675716-104675717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192013570 | chr1:104675756-104675757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576452149 | chr1:104675812-104675813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543808851 | chr1:104675814-104675815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561888147 | chr1:104675820-104675821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572683162 | chr1:104675845-104675846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104668400-104674800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr1:104669400-104678400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr1:104674200-104675600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr1:104674800-104675400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr1:104674800-104675400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr1:104674800-104675400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr1:104674800-104675600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr1:104674800-104675600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr1:104675200-104675600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr1:104675200-104675600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr1:104675400-104676800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr1:104675400-104677800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
13 | chr1:104675600-104676600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr1:104675600-104676800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr1:104675600-104678400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr1:104675600-104678400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
17 | chr1:104675600-104679200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
18 | chr1:104676600-104677200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
19 | chr1:104676800-104677400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr1:104676800-104679800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
21 | chr1:104677200-104677400 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
22 | chr1:104677400-104678400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |